MYndspan
About MYndspan
MYndspan is a brain analytics company enabling users to assess and monitor brain health to extend the healthy lifespan of the mind.
Using clinical-grade MEG scanning and validated metrics, MYndspan provides clear, objective insights into brain function to enable early action and tracking changes over time. Their mission is to end preventable neurodegeneration through early detection by giving people the tools to understand and monitor their brain health with clinical precision.
They are the first company to offer advanced MEG technology directly to consumers, starting with their flagship scanning site in London.
Company Details
Industry: Wellness and Fitness Services
Company size: 2-10 employees
Headquarters: London, United Kingdom
Founded: 2020
Type: Privately Held
Leadership
Caitlin Baltzer, Co-Founder and CEO with background in MEG commercial strategy and finance.
Dr. Benjamin Dunkley, Chief Science Officer, neuroscientist and MEG expert.
Janne Huhtala, Founder and Executive Chair, with over 15 years in neuromodulation.
Mission and Goals
MYndspan aims to provide advanced brain health assessments outside research labs for everyday life, enabling early intervention which could prevent up to 45% of dementia cases.
